E-drug: TACD on Pharma Registration Data Exclusivity (cont'd)
-------------------------------------------------------------------------
Jamie,
Just one point:
The 10 year data exclusivity period was indeed introduced to make
up for a lack of patent protection though mainly for biotech products
and not so much for lack of patent laws in Spain and Portugal.
However, you are quite right to emphasise tht since EU national laws
and TRIPs have provided for 20 year patents the arguments for such
long data exclusivity should end. Indeed the EU has now adopted a
Bio-tech patent and this should make the 10 year data exclusivity
period unnecessary. This may be a very good point for you to push.
Greg
Greg Perry
Director General
European Generic Medicines Association (EGA)
PO Box 193
Brussels 1040, Belgium
Tel 32.2.7368411
Fax: 32 2 7367438
e mail: gperry@egagenerics.com
web: www.egagenerics.com
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.